Mizuho Markets Cayman’s Biogen BIIB Stock Holding History

Mizuho Markets Cayman’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,615	Closed	-$724K	–	96
2022 Q4	$724K	Buy	+2,615	New	+$739K	0.09%	52
2022 Q1	–	Sell	-2,335	Closed	-$560K	–	118
2021 Q4	$560K	Sell	2,335 -3,812	-62%	-$980K	0.04%	68
2021 Q3	$1.74M	Buy	+6,147	New	+$2.01M	0.12%	43
2021 Q2	–	Sell	-786	Closed	-$220K	–	99
2021 Q1	$220K	Buy	+786	New	+$212K	0.02%	73
2020 Q4	–	Sell	-1,242	Closed	-$352K	–	71
2020 Q3	$352K	Buy	+1,242	New	+$346K	0.06%	47
2020 Q2	–	Sell	-3,009	Closed	-$952K	–	69
2020 Q1	$952K	Buy	+3,009	New	+$913K	0.22%	26

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mizuho Markets Cayman's BIIB Position: Q1 2023 in Review

Mizuho Markets Cayman sold out of Biogen (BIIB) in Q1 2023, closing a stake of 2,615 shares — an estimated $724K sold.

Mizuho Markets Cayman first reported a position in BIIB in Q1 2020 and held it in 6 quarters. The position peaked at $1.74M in Q3 2021. 1,001 funds tracked by Wall St. Rank hold BIIB as of Q1 2023.

Mizuho Markets Cayman reported no remaining Biogen position as of Q1 2023 after selling out during the quarter.
Mizuho Markets Cayman sold 2,615 Biogen shares in Q1 2023, an estimated $724K.
Mizuho Markets Cayman first reported a position in Biogen in Q1 2020 and held it in 6 quarters.
Mizuho Markets Cayman's Biogen position peaked at $1.74M in Q3 2021.
1,001 funds tracked by Wall St. Rank held Biogen as of Q1 2023.

Based on Mizuho Markets Cayman's 13F filing for Q1 2023, filed 3 May 2023.